Hasbro vs Takara Bio

Hasbro and Takara Bio are two major players in the toy and entertainment industries, with a focus on creating popular brands such as Transformers and Beyblade. The rivalry between these companies has been ongoing for decades, as they compete for market share and consumer loyalty. Both companies have seen success and growth in recent years, with Hasbro's stock performing well in the market, while Takara Bio has carved out a niche for itself in the world of biotechnology and pharmaceuticals. Investors and analysts closely monitor the performance of these companies, eager to see who will come out on top in this ongoing battle for dominance.

Hasbro or Takara Bio?

When comparing Hasbro and Takara Bio, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Hasbro and Takara Bio.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Hasbro has a dividend yield of 3.91%, while Takara Bio has a dividend yield of 1.59%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Hasbro reports a 5-year dividend growth of 2.62% year and a payout ratio of -37.55%. On the other hand, Takara Bio reports a 5-year dividend growth of 0.00% year and a payout ratio of 1886.84%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Hasbro P/E ratio at -9.65 and Takara Bio's P/E ratio at 1131.27. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Hasbro P/B ratio is 8.69 while Takara Bio's P/B ratio is 1.16.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Hasbro has seen a 5-year revenue growth of -0.01%, while Takara Bio's is 0.21%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Hasbro's ROE at -76.12% and Takara Bio's ROE at 0.10%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are $71.52 for Hasbro and ¥1049.00 for Takara Bio. Over the past year, Hasbro's prices ranged from $42.66 to $73.46, with a yearly change of 72.20%. Takara Bio's prices fluctuated between ¥930.00 and ¥1350.00, with a yearly change of 45.16%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.